PAR-20-077 - National Cancer Institute Program Project Applications (P01 Clinical Trial Optional) is used for the submission of applications to the following Notices of Special Interest (NOSIs)
On This Page: 11
Active NOSIs
Title | Notice Number | Organization | Release Date |
Expiration Date |
Activity Code(s) |
---|
Expired NOSIs
Title | Notice Number | Organization | Release Date |
Expiration Date |
Activity Code(s) |
---|---|---|---|---|---|
Notice of Special Interest (NOSI): Research on the Etiology, Early Detection, Screening and Prevention of Early-Onset Colorectal Cancer | NOT-CA-23-018 | NCI | Jan 19, 2023 | Sep 8, 2024 | K01, R01, K22, K08, R21, U34, K99/R00, P01, R34 |
Notice of Special Interest (NOSI): Addressing Cancer-Related Financial Hardship to Improve Patient Outcomes | NOT-CA-22-045 | NCI | Feb 3, 2022 | Mar 1, 2024 | P01, R21, R01, R03 |
Notice of Special Interest (NOSI): Disparities Affecting Healthcare Utilization and Health Outcomes Among Childhood Cancer Survivors | NOT-CA-22-029 | NCI | Jan 7, 2022 | Oct 9, 2024 | R01, R21, P01, R03 |
Notice of Special Interest (NOSI): Research on Interprofessional Teamwork and Coordination During Cancer Diagnosis and Treatment | NOT-CA-22-014 | NCI | Dec 8, 2021 | Oct 9, 2024 | R03, R01, R21, P01 |
Notice of Special Interest (NOSI): Accelerating Progress in Celiac Disease Research | NOT-AI-22-004 | NIAID NIAMS NCCIH NCI | Nov 23, 2021 | Jan 8, 2025 | R03, R21, U01, U44, R01, R34, P01, R61/R33 |
Notice of Special Interest (NOSI): Improving Outcomes in Cancer Treatment-Related Cardiotoxicity | NOT-CA-22-001 | NCI NHLBI | Nov 4, 2021 | Nov 6, 2024 | R01, R03, R21, P01 |
Notice of Special Interest (NOSI): Clinical Characterization and Intervention Strategies for Cancer Therapy Induced Adverse Sequelae | NOT-CA-22-005 | NCI | Oct 28, 2021 | May 8, 2023 | P01 |
Notice of Special Interest (NOSI): Expanding Cancer Control Research in Persistent Poverty Areas | NOT-CA-21-071 | NCI | Apr 27, 2021 | May 8, 2023 | P01 |
Notice of Special Interest (NOSI): Understanding the effects of cancer and cancer treatment on aging trajectories and aging outcomes | NOT-CA-21-031 | NCI NIA | Jan 27, 2021 | Jan 8, 2024 | R21, R03, R01, U01, P01, K99/R00, K08, R43/R44, R41/R42, R13, R21/R33, K01, K23 |
Notice of Special Interest (NOSI): Single-Cell Proteomics for Interrogating Premalignant and Early Malignant Lesions | NOT-CA-20-044 | NCI | Apr 9, 2020 | May 8, 2023 | R03, R21, R01, P01 |
Notice of Special Interest (NOSI): Research on Oral Anticancer Agents in the Contexts of Utilization, Adherence, and Health Care Delivery | NOT-CA-20-026 | NCI | Feb 21, 2020 | May 8, 2023 | R01, R21, R03, P01 |